Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

NICE rejects Roche's breast cancer drug Perjeta

NICE rejects Roche's breast cancer drug Perjeta The draft guidance suggests NICE would like to see more data on the benefits of adding Perjeta (pertuzumab) to treatment with chemotherapy or Roche's Herceptin (trastuzumab) - particularly its effect on ... Perjeta is used alongside Herceptin or

Cancer drugs help Roche beat expectations in first quarter

Cancer drugs help Roche beat expectations in first quarter Sales of Roche's top-seller MabThera rose 3% to CHF1.83bn, with Herceptin and Avastin rising 4% apiece to CHF1.73bn and CHF1.71bn, respectively. ... For now Roche has been insulated from any impact from biosimilar competition, although it does anticipate

Roche shares slip as profits miss expectations

Roche shares slip as profits miss expectations For 2015, pharma sales were up 5% to CHF 37.3bn on the back of good performances by cancer drugs particularly Roche's HER2 inhibitor franchise - Herceptin (trastuzumab), Kadcyla (trastuzumab/emtansine) ... an expected slowdown for some of its big-selling

FDA verdict on Amgen's Humira biosimilar due in September

FDA verdict on Amgen's Humira biosimilar due in September Amgen's biosimilar pipeline also include a version of Roche's breast and gastric cancer therapy Herceptin (trastuzumab) and Avastin (bevacizumab), used in several solid tumour types including colorectal and

UK Prix Galien opens for entries

UK Prix Galien opens for entries Pharma R&D accolades will include a new real world evidence category

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics